Complementary and alternative medicine use in adolescents with inflammatory bowel disease and juvenile idiopathic arthritis

详细信息    查看全文

• 作者：Pauliina Nousiainen (1)
  Laura Merras-Salmio (2)
  Kristiina Aalto (2)
  Kaija-Leena Kolho (2)
  
• 关键词：Children ; Colitis ulcerative ; Crohn’s disease ; Juvenile idiopathic arthritis ; Paediatric
• 刊名：BMC Complementary and Alternative Medicine
• 出版年：2014
• 出版时间：December 2014
• 年：2014
• 卷：14
• 期：1
• 全文大小：167 KB
• 参考文献：1. Molodecky NA, Soon IS, Rabi DM, Ghali WA, Ferris M, Chernoff G, Benchimol EI, Panaccione R, Ghosh S, Barkema HW, Kaplan GG: Increasing incidence and prevalence of the inflammatory bowel diseases with time, based on systematic review. / Gastroenterology 2012,142(1):46-4. e42 CrossRef
  2. Lehtinen P, Ashorn M, Iltanen S, Jauhola R, Jauhonen P, Kolho KL, Auvinen A: Incidence trends of pediatric inflammatory bowel disease in Finland, 1987-003, a nationwide study. / Inflamm Bowel Dis 2011,17(8):1778-783. CrossRef
  3. Marcus SB, Strople JA, Neighbors K, Weissberg-Benchell J, Nelson SP, Limbers C, Varni JW, Alonso EM: Fatigue and health-related quality of life in pediatric inflammatory bowel disease. / Clin Gastroenterol Hepatol 2009,7(5):554-61. CrossRef
  4. Haapamaki J, Roine RP, Sintonen H, Kolho KL: Health-related quality of life in paediatric patients with inflammatory bowel disease related to disease activity. / J Paediatr Child Health 2011,47(11):832-37. CrossRef
  5. Vaisto T, Aronen ET, Simola P, Ashorn M, Kolho KL: Psychosocial symptoms and competence among adolescents with inflammatory bowel disease and their peers. / Inflamm Bowel Dis 2010,16(1):27-5. CrossRef
  6. Mackner LM, Greenley RN, Szigethy E, Herzer M, Deer K, Hommel KA: Psychosocial issues in pediatric inflammatory bowel disease: report of the North American Society for Pediatric Gastroenterology, Hepatology, and Nutrition. / J Pediatr Gastroenterol Nutr 2013,56(4):449-58. CrossRef
  7. Castaneda AE, Tuulio-Henriksson A, Aronen ET, Marttunen M, Kolho KL: Cognitive functioning and depressive symptoms in adolescents with inflammatory bowel disease. / World J Gastroenterol 2013,19(10):1611-617. CrossRef
  8. Wilson DC, Thomas AG, Croft NM, Newby E, Akobeng AK, Sawczenko A, Fell JM, Murphy MS, Beattie RM, Sandhu BK, Mitton SG, Casson D, Elawad M, Heuschkel R, Jenkins H, Johnson T, Macdonald S, Murch SH, IBD Working Group of the British Society of Paediatric Gastroenterology, Hepatology, and Nutrition: Systematic review of the evidence base for the medical treatment of paediatric inflammatory bowel disease. / J Pediatr Gastroenterol Nutr 2010,50(Suppl 1):S14-4. CrossRef
  9. Virta LJ, Kolho KL: Trends in early outpatient drug therapy in pediatric inflammatory bowel disease in Finland: a nationwide register-based study in 1999-009. / ISRN Gastroenterol 2012, 2012:462642. CrossRef
  10. Berntson L, Andersson Gare B, Fasth A, Herlin T, Kristinsson J, Lahdenne P, Marhaug G, Nielsen S, Pelkonen P, Rygg M: Incidence of juvenile idiopathic arthritis in the Nordic countries. A population based study with special reference to the validity of the ILAR and EULAR criteria. / J Rheumatol 2003,30(10):2275-282.
  11. Nordal E, Zak M, Aalto K, Berntson L, Fasth A, Herlin T, Lahdenne P, Nielsen S, Straume B, Rygg M: Ongoing disease activity and changing categories in a long-term nordic cohort study of juvenile idiopathic arthritis. / Arthritis Rheum 2011,63(9):2809-818. CrossRef
  12. Giancane G, Pederzoli S, Norambuena X, Ioseliani M, Sato J, Gallo MC, Negro G, Pistorio A, Ruperto N, Martini A, Ravelli A: Frequency of radiographic damage and progression in individual joints in children with juvenile idiopathic arthritis. / Arthritis Care Res (Hoboken) 2013, 66:27-3. CrossRef
  13. Shenoi S, Wallace CA: Remission in juvenile idiopathic arthritis: current facts. / Curr Rheumatol Rep 2010,12(2):80-6. CrossRef
  14. Beukelman T, Patkar NM, Saag KG, Tolleson-Rinehart S, Cron RQ, DeWitt EM, Ilowite NT, Kimura Y, Laxer RM, Lovell DJ, Martini A, Rabinovich CE, Ruperto N: American college of rheumatology recommendations for the treatment of juvenile idiopathic arthritis: initiation and safety monitoring of therapeutic agents for the treatment of arthritis and systemic features. / Arthritis Care Res (Hoboken) 2011,63(4):465-82. CrossRef
  15. Opheim R, Hoivik ML, Solberg IC, Moum B: Complementary and alternative medicine in patients with inflammatory bowel disease: the results of a population-based inception cohort study (IBSEN). / J Crohns Colitis 2012,6(3):345-53. CrossRef
  16. Hagen LE, Schneider R, Stephens D, Modrusan D, Feldman BM: Use of complementary and alternative medicine by pediatric rheumatology patients. / Arthritis Rheum 2003,49(1):3-. CrossRef
  17. Complementary, Alternative, or Integrative Health: What′s In a Name? [http://nccam.nih.gov/health/whatiscam], accessed Nov 21, 2013
  18. Hilsden RJ, Verhoef MJ, Rasmussen H, Porcino A, DeBruyn JC: Use of complementary and alternative medicine by patients with inflammatory bowel disease. / Inflamm Bowel Dis 2011,17(2):655-62. CrossRef
  19. Bunchorntavakul C, Reddy KR: Review article: herbal and dietary supplement hepatotoxicity. / Aliment Pharmacol Ther 2013,37(1):3-7. CrossRef
  20. Otley AR, Verhoef MJ, Best A, Hilsden RJ: Prevalence and determinants of use of complementary and alternative medicine in a Canadian pediatric inflammatory bowel disease (IBD) population. / Gastroenterology 2001,120(5 (Supplement 1))):A213. CrossRef
  21. Gerasimidis K, McGrogan P, Hassan K, Edwards CA: Dietary modifications, nutritional supplements and alternative medicine in paediatric patients with inflammatory bowel disease. / Aliment Pharmacol Ther 2008,27(2):155-65. CrossRef
  22. Heuschkel R, Afzal N, Wuerth A, Zurakowski D, Leichtner A, Kemper K, Tolia V, Bousvaros A: Complementary medicine use in children and young adults with inflammatory bowel disease. / Am J Gastroenterol 2002,97(2):382-88. CrossRef
  23. Markowitz JE, Mamula P, delRosario JF, Baldassano RN, Lewis JD, Jawad AF, Culton K, Strom BL: Patterns of complementary and alternative medicine use in a population of pediatric patients with inflammatory bowel disease. / Inflamm Bowel Dis 2004,10(5):599-05. CrossRef
  24. Wong AP, Clark AL, Garnett EA, Acree M, Cohen SA, Ferry GD, Heyman MB: Use of complementary medicine in pediatric patients with inflammatory bowel disease: results from a multicenter survey. / J Pediatr Gastroenterol Nutr 2009,48(1):55-0. CrossRef
  25. Day AS, Whitten KE, Bohane TD: Use of complementary and alternative medicines by children and adolescents with inflammatory bowel disease. / J Paediatr Child Health 2004,40(12):681-84. CrossRef
  26. Feldman DE, Duffy C, De Civita M, Malleson P, Philibert L, Gibbon M, Ortiz-Alvarez O, Dobkin PL: Factors associated with the use of complementary and alternative medicine in juvenile idiopathic arthritis. / Arthritis Rheum 2004,51(4):527-32. CrossRef
  27. Zebracki K, Holzman K, Bitter KJ, Feehan K, Miller ML: Brief report: use of complementary and alternative medicine and psychological functioning in Latino children with juvenile idiopathic arthritis or arthralgia. / J Pediatr Psychol 2007,32(8):1006-010. CrossRef
  28. April KT, Feldman DE, Zunzunegui MV, Descarreaux M, Malleson P, Duffy CM: Longitudinal analysis of complementary and alternative health care use in children with juvenile idiopathic arthritis. / Complement Ther Med 2009,17(4):208-15. CrossRef
  29. Rouster-Stevens K, Nageswaran S, Arcury TA, Kemper KJ: How do parents of children with juvenile idiopathic arthritis (JIA) perceive their therapies? / BMC Complement Altern Med 2008, 8:25. CrossRef
  30. Consolaro A, Ruperto N, Bazso A, Pistorio A, Magni-Manzoni S, Filocamo G, Malattia C, Viola S, Martini A, Ravelli A: Development and validation of a composite disease activity score for juvenile idiopathic arthritis. / Arthritis Rheum 2009,61(5):658-66. CrossRef
  31. Birdee GS, Phillips RS, Davis RB, Gardiner P: Factors associated with pediatric use of complementary and alternative medicine. / Pediatrics 2010,125(2):249-56. CrossRef
  32. Davis MP, Darden PM: Use of complementary and alternative medicine by children in the United States. / Arch Pediatr Adolesc Med 2003,157(4):393-96. CrossRef
  33. April KT, Walji R: The state of research on complementary and alternative medicine in pediatric rheumatology. / Rheum Dis Clin North Am 2011,37(1):85-4. CrossRef
  34. Li FX, Verhoef MJ, Best A, Otley A, Hilsden RJ: Why patients with inflammatory bowel disease use or do not use complementary and alternative medicine: a Canadian national survey. / Can J Gastroenterol 2005,19(9):567-73.
  35. Weizman AV, Ahn E, Thanabalan R, Leung W, Croitoru K, Silverberg MS, Steinhart AH, Nguyen GC: Characterisation of complementary and alternative medicine use and its impact on medication adherence in inflammatory bowel disease. / Aliment Pharmacol Ther 2012,35(3):342-49. CrossRef
  36. Quattropani C, Ausfeld B, Straumann A, Heer P, Seibold F: Complementary alternative medicine in patients with inflammatory bowel disease: use and attitudes. / Scand J Gastroenterol 2003,38(3):277-82.
  37. Teschke R, Schulze J, Schwarzenboeck A, Eickhoff A, Frenzel C: Herbal hepatotoxicity: suspected cases assessed for alternative causes. / Eur J Gastroenterol Hepatol 2013, 46:264-69.
  38. The pre-publication history for this paper can be accessed here: http://www.biomedcentral.com/1472-6882/14/124/prepub
  
• 作者单位：Pauliina Nousiainen (1)
  Laura Merras-Salmio (2)
  Kristiina Aalto (2)
  Kaija-Leena Kolho (2)
  
  1. Department of Pediatrics, Kuopio University Hospital and University of Helsinki, Kuopio, Finland
  2. Children’s Hospital, Helsinki University Central Hospital and University of Helsinki, P.O. Box 281, Helsinki, Finland
  
• ISSN：1472-6882

文摘

Background The use of complementary alternative medicine (CAM) is potentially prevalent among paediatric patients with chronic diseases but with variable rates among different age groups, diseases and countries. There are no recent reports on CAM use among paediatric patients with inflammatory bowel disease (IBD) and juvenile idiopathic arthritis (JIA) in Europe. We hypothesized that CAM use associates with a more severe disease in paediatric IBD and JIA. Methods A cross-sectional questionnaire study among adolescent outpatients with IBD and JIA addressing the frequency and type of CAM use during the past year. The patients were recruited at the Children’s Hospital, University of Helsinki, Finland. Results Of the 147 respondents, 97 had IBD (Crohn’s disease: n--6; median age 15.5, disease duration 3.4?years) and 50 had JIA (median age 13.8, disease duration 6.9?years). During the past 12?months, 48% regularly used CAM while 81% reported occasional CAM use. Compared to patients with JIA, the use of CAM in IBD patients tended to be more frequent. The most commonly used CAM included probiotics, multivitamins, and mineral and trace element supplements. Self-imposed dietary restrictions were common, involving 27.6% of the non-CAM users but 64.8% of all CAM users. Disease activity was associated with CAM use in JIA but not in IBD. Conclusions CAM use is frequent among adolescents with IBD and JIA and associates with self-imposed dietary restrictions. Reassuringly, adherence to disease modifying drugs is good in young CAM users. In JIA, patients with active disease used more frequently CAM than patients with inactive disease. As CAM use is frequent, physicians should familiarise themselves with the basic concepts of CAM. The potential pharmacological interaction or the toxicity of certain CAM products warrants awareness and hence physicians should actively ask their patients about CAM use.